Aziyo Biologics GAAP EPS of -$0.49 beats by $0.05, revenue of $13.1M misses by $0.6M

Stock Information for Aziyo Biologics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aziyo Biologics Inc.

Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.